Celsion’s GEN-1 Immunotherapy Receives Orphan Drug Designation from the European Medicines Agency
Approval Adds 10 Years of Market Exclusivity Following Marketing Authorization in EuropeLAWRENCEVILLE, N.J., March 23, 2020 (GLOBE NEWSWIRE) — Celsion […]